These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 15173840)

  • 1. Antimalarial drug discovery: efficacy models for compound screening.
    Fidock DA; Rosenthal PJ; Croft SL; Brun R; Nwaka S
    Nat Rev Drug Discov; 2004 Jun; 3(6):509-20. PubMed ID: 15173840
    [No Abstract]   [Full Text] [Related]  

  • 2. Tolerance is the key to understanding antimalarial drug resistance.
    Hastings IM; Watkins WM
    Trends Parasitol; 2006 Feb; 22(2):71-7. PubMed ID: 16406706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Current perspectives in antimalarial therapy].
    Le Bras J
    Med Trop (Mars); 1995; 55(3 Suppl):13-7. PubMed ID: 8609816
    [No Abstract]   [Full Text] [Related]  

  • 4. Recent advances in antimalarial drug development.
    Vangapandu S; Jain M; Kaur K; Patil P; Patel SR; Jain R
    Med Res Rev; 2007 Jan; 27(1):65-107. PubMed ID: 16700012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical evaluation of antimalarial treatment response.
    White NJ
    Acta Leiden; 1991; 60(1):141-6. PubMed ID: 1820703
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistance to antimalarial compounds: methods and applications.
    Witkowski B; Berry A; Benoit-Vical F
    Drug Resist Updat; 2009; 12(1-2):42-50. PubMed ID: 19285915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current drug development portfolio for antimalarial therapies.
    Biagini GA; O'Neill PM; Bray PG; Ward SA
    Curr Opin Pharmacol; 2005 Oct; 5(5):473-8. PubMed ID: 16084770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawing antimalarial drugs: impact on parasite resistance and implications for malaria treatment policies.
    Laufer MK; Plowe CV
    Drug Resist Updat; 2004; 7(4-5):279-88. PubMed ID: 15533765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malaria chemotherapeutics part I: History of antimalarial drug development, currently used therapeutics, and drugs in clinical development.
    Schlitzer M
    ChemMedChem; 2007 Jul; 2(7):944-86. PubMed ID: 17530725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimalarial drug discovery: old and new approaches.
    Rosenthal PJ
    J Exp Biol; 2003 Nov; 206(Pt 21):3735-44. PubMed ID: 14506208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimalarial drug resistance and the importance of drug quality monitoring.
    Green MD
    J Postgrad Med; 2006; 52(4):288-90. PubMed ID: 17102548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug resistance models for malaria.
    Mackinnon MJ
    Acta Trop; 2005 Jun; 94(3):207-17. PubMed ID: 15894181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimalarial drugs - what is in use and what is in the pipeline.
    Schlitzer M
    Arch Pharm (Weinheim); 2008 Mar; 341(3):149-63. PubMed ID: 18297679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feeding the antimalarial pipeline.
    Schlitzer M; Ortmann R
    ChemMedChem; 2010 Nov; 5(11):1837-40. PubMed ID: 20922746
    [No Abstract]   [Full Text] [Related]  

  • 16. Toy kit against malaria: magic bullets, LEGO, Trojan horses and Russian dolls.
    Fernàndez-Busquets X
    Ther Deliv; 2014 Oct; 5(10):1049-52. PubMed ID: 25418263
    [No Abstract]   [Full Text] [Related]  

  • 17. Effectiveness of antimalarial drugs.
    Smego RA
    N Engl J Med; 2005 Jul; 353(4):420-2; author reply 420-2. PubMed ID: 16050053
    [No Abstract]   [Full Text] [Related]  

  • 18. The impact of antimalarial drug resistance mutations on parasite fitness, and its implications for the evolution of resistance.
    Hastings IM; Donnelly MJ
    Drug Resist Updat; 2005; 8(1-2):43-50. PubMed ID: 15939341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment for malaria].
    Stock I
    Med Monatsschr Pharm; 2004 Aug; 27(8):260-72; quiz 273-4. PubMed ID: 15382449
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.